Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
From Structure Modification to Drug Launch: A Systematic Reviewof the Ongoing Development of Cyclin-Dependent Kinase Inhibitorsfor Multiple Cancer Therapy
Zhenfeng Shi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Enhancing the tropism of bacteria via genetically programmed biosensors
Tiffany Chien et al.
NATURE BIOMEDICAL ENGINEERING (2022)
A rapid screening platform to coculture bacteria within tumor spheroids
Tetsuhiro Harimoto et al.
NATURE PROTOCOLS (2022)
Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer
Lin Yu et al.
JOURNAL OF DRUG TARGETING (2021)
The composition of lung microbiome in lung cancer: a systematic review and meta-analysis
Sadaf Najafi et al.
BMC MICROBIOLOGY (2021)
Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases
Vishnu Raman et al.
NATURE COMMUNICATIONS (2021)
Intestinal organoid cocultures with microbes
Jens Puschhof et al.
NATURE PROTOCOLS (2021)
Microbiome dysbiosis in lung cancer: from composition to therapy
Ning-Ning Liu et al.
NPJ PRECISION ONCOLOGY (2020)
The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy
Ariel G. Ramirez-Labrada et al.
TRENDS IN CANCER (2020)
Rapid screening of engineered microbial therapies in a 3D multicellular model
Tetsuhiro Harimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
Ahmed Salem et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Expansion of the Clostridium perfringens toxin-based typing scheme
Julian I. Rood et al.
ANAEROBE (2018)
Evaluation of the airway microbiome in nontuberculous mycobacteria disease
Imran Sulaiman et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non-Small Cell Lung Cancers
Dhruba Deb et al.
CANCER RESEARCH (2017)
Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer
Jae-Young Kim et al.
MOLECULAR CANCER RESEARCH (2016)
Somatic mutation in cancer and normal cells
Inigo Martincorena et al.
SCIENCE (2015)
Non-small-cell lung cancers: a heterogeneous set of diseases
Zhao Chen et al.
NATURE REVIEWS CANCER (2014)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Bacterial therapies: completing the cancer treatment toolbox
Adam T. St Jean et al.
CURRENT OPINION IN BIOTECHNOLOGY (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium
M Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)